News

Share

Endogenex CEO Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes (Podcast)

With a background as a trauma nurse and experience running clinical research programs, Stacey Pugh brought quite a bit of patient-focused experience with her when she shifted to industry. After several roles in the neurovascular space, now she’s leading the charge at Endogenex, which is using pulsed electric fields to treat Type 2 Diabetes. She and host, Geoff Pardo, talk about a medical officer’s first experience doing sales, the challenges in affecting change management in primary care, funding businesses with SPACs, and more.

Listen to the full podcast at MedtechTalk »

Scroll to Top